Additional information Use in sports Not commonly used due to its specific medical application for reducing excess abdominal fat in HIV-infected patients with lipodystrophy Formula C221H366N72O67S Side effects Injection site reactions (redness, itching, pain), muscle aches, swelling, and potential increase in blood sugar levels Effects Increases natural production of growth hormone Dosage (sports) Not applicable as it is not typically used for sports enhancement Dosage (medical) 2 mg injected subcutaneously once daily Half-life Approximately 38 minutes Main action Growth hormone-releasing hormone (GHRH) analog Substance class Peptide hormone Chemical name (trans-3-Hexenoyl)lysyl-threonyl-threonyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl Storage conditions Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) Trade name Egrifta Blood pressure Typically no significant impact on blood pressure Also known as TH9507 Lab Test Monitoring of IGF-1 levels may be used to assess efficacy Hepatotoxicity No significant hepatotoxicity reported Water Retention Minimal Raw Material Human Growth Hormone Manufacturer Generic blue top Packing Tesamorelin 2mg
